News
The global Therapeutic Respiratory Devices Market is estimated to be valued at USD 55.40 billion in 2025 and is projected to reach USD 86.03 billion by 2035, registering a compound annual growth rate ...
There is a need to re-evaluate the concept of asthma and chronic obstructive pulmonary disease (COPD) as separate conditions, and to consider situations when they may coexist, or when one condition ...
Pulmonary Drug Delivery System Market Size to Worth USD 73.14 Billion by 2031 | The Insight Partners
According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...
The study found that COPD patients’ alveolar macrophages — a type of lung cell that removes dust, particles and microorganisms from the lungs — contain more carbon than those of smokers. The ...
Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...
Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but access is still a challenge. "The science shows that there is greater ...
Find patient medical information for Saline (Sodium Chloride) for Nebulization on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...
Many people with chronic lung diseases such as COPD or asthma use a nebulizer to take their medication in the form of a mist that is inhaled into the lungs. Nebulizers are often recommended for ...
Multiple Conditions Evidence Significant Associations In both the discovery and validation datasets, chronic obstructive pulmonary disease (COPD) was the strongest predictor of LCINS, according to the ...
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.
COPD — chronic obstructive pulmonary disease — “is a tough disease,” says Colleen Brennan-Martinez, 64, a retired nurse practitioner from New York City whose father, James Brennan, died from COPD in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results